Skip to main content

Dr Lawrence Barrera Briceno
BSc (Hons), MSc, PhD, AFHE, MRSB

Publications

What type of publication do you want to show?

2023

2021

2020

Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers

Oldfield, L., Barrera, L., Williams, D., Evans, A. E., Neoptolemos, J., & Costello, E. (2020). Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers. In Molecular and Translational Medicine (pp. 73-82). Springer International Publishing. doi:10.1007/978-3-030-49476-6_4

DOI
10.1007/978-3-030-49476-6_4
Chapter

2019

PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts

Barrera, L. N., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2019). PDAC-associated fibroblasts are less responsive to an anti-fibrotic stimulus and more responsive to a positive regulator of fibroblast activation than normal activated fibroblasts. Pancreatology, 19, S158. doi:10.1016/j.pan.2019.05.423

DOI
10.1016/j.pan.2019.05.423
Journal article

2018

Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile

Barrera, L., Evans, A., Lane, B., Brumskill, S., Oldfield, F., Campbell, F., . . . Costello, E. (2018). Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile. Pancreatology, 18(4), S94. doi:10.1016/j.pan.2018.05.254

DOI
10.1016/j.pan.2018.05.254
Journal article

The efficacy of brusatol as a chemotherapeutic agent in pancreatic cancer and its relevance to potential chemoresistance conferred by Nrf2

Williams, D., Gayon, S., Barrera, L., Perez-Mancera, P., Copple, I., Goldring, C., . . . Costello, E. (2018). The efficacy of brusatol as a chemotherapeutic agent in pancreatic cancer and its relevance to potential chemoresistance conferred by Nrf2. Pancreatology, 18(4), S149. doi:10.1016/j.pan.2018.05.400

DOI
10.1016/j.pan.2018.05.400
Journal article

Development of Novel Diagnostic Pancreatic Tumor Biomarkers

Oldfield, L., Rao, R., Barrera, L. N., & Costello, E. (2018). Development of Novel Diagnostic Pancreatic Tumor Biomarkers. In Pancreatic Cancer (pp. 1241-1272). Springer New York. doi:10.1007/978-1-4939-7193-0_86

DOI
10.1007/978-1-4939-7193-0_86
Chapter

2017

Modelling the Tumour Microenvironment in Pancreatic Ductal Adenocarcinoma

Brumskill, S., Barrera, L., Campbell, F., Halloran, C., Neoptolemos, J., Sutton, R., . . . Costello, E. (2017). Modelling the Tumour Microenvironment in Pancreatic Ductal Adenocarcinoma. Pancreatology, 17(3), S4. doi:10.1016/j.pan.2017.05.011

DOI
10.1016/j.pan.2017.05.011
Journal article

2016

Circulating tenascin C levels distinguish pancreatic cancer from chronic pancreatitis and correlate with pancreatic stromal expression

Evans, A., Jenkinson, C., Barrera, L., Oldfield, F., Rimmer, N., Garner, E., . . . Costello, E. (2016). Circulating tenascin C levels distinguish pancreatic cancer from chronic pancreatitis and correlate with pancreatic stromal expression. Pancreatology, 16(3), S30-S31. doi:10.1016/j.pan.2016.05.105

DOI
10.1016/j.pan.2016.05.105
Journal article

Identification of novel signalling pathways dysregulated in pancreatic cancer-associated fibroblasts

Barrera, L., Lane, B., Brumskill, S., Oldfield, F., Lamond, R., Wilkinson, L., . . . Costello, E. (2016). Identification of novel signalling pathways dysregulated in pancreatic cancer-associated fibroblasts. Pancreatology, 16(3), S31. doi:10.1016/j.pan.2016.05.106

DOI
10.1016/j.pan.2016.05.106
Journal article

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis

Abu-Alainin, W., Gana, T., Liloglou, L., Olayanju, A., Barrera Briceno, L., Ferguson, R., . . . Costello-Goldring, E. (2016). UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis. Journal of Pathology, 238(3), 423-433. doi:10.1002/path.4665

DOI
10.1002/path.4665
Journal article

2015

Simultaneous integration of microRNA and mRNA expression in the analysis of quiescent and activated human fibroblasts in the diseased pancreas

Barrera, L., Lane, B., Brumskill, S., Oldfield, F., Nunes, Q., Campbell, F., . . . Costello, E. (2015). Simultaneous integration of microRNA and mRNA expression in the analysis of quiescent and activated human fibroblasts in the diseased pancreas. Pancreatology, 15(3), S19-S20. doi:10.1016/j.pan.2015.05.103

DOI
10.1016/j.pan.2015.05.103
Journal article

2014

2013

Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro.

Barrera, L. N., Johnson, I. T., Bao, Y., Cassidy, A., & Belshaw, N. J. (2013). Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro.. European journal of nutrition, 52(4), 1327-1341. doi:10.1007/s00394-012-0442-1

DOI
10.1007/s00394-012-0442-1
Journal article

Isolation of pancreatic stellate cells for future analysis of microRNA

Barrera, L., Oldfield, F., Nunes, Q., Campbell, F., Lane, B., Andrews, T., . . . Costello, E. (2013). Isolation of pancreatic stellate cells for future analysis of microRNA. Pancreatology, 13(3), S58. doi:10.1016/j.pan.2013.04.205

DOI
10.1016/j.pan.2013.04.205
Journal article

BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB

Rushworth, S. A., Bowles, K. M., Barrera, L. N., Murray, M. Y., Zaitseva, L., & MacEwan, D. J. (2013). BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB. CELLULAR SIGNALLING, 25(1), 106-112. doi:10.1016/j.cellsig.2012.09.008

DOI
10.1016/j.cellsig.2012.09.008
Journal article

2012

TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death.

Barrera, L. N., Cassidy, A., Wang, W., Wei, T., Belshaw, N. J., Johnson, I. T., . . . Bao, Y. (2012). TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death.. Biochimica et biophysica acta, 1823(10), 1914-1924. doi:10.1016/j.bbamcr.2012.07.007

DOI
10.1016/j.bbamcr.2012.07.007
Journal article

Synergy between sulforaphane and selenium in the up-regulation of thioredoxin reductase and protection against hydrogen peroxide-induced cell death in human hepatocytes.

Li, D., Wang, W., Shan, Y., Barrera, L. N., Howie, A. F., Beckett, G. J., . . . Bao, Y. (2012). Synergy between sulforaphane and selenium in the up-regulation of thioredoxin reductase and protection against hydrogen peroxide-induced cell death in human hepatocytes.. Food chemistry, 133(2), 300-307. doi:10.1016/j.foodchem.2012.01.026

DOI
10.1016/j.foodchem.2012.01.026
Journal article

Bortezomib induces heme oxygenase-1 expression in multiple myeloma

Barrera, L. N., Rushworth, S. A., Bowles, K. M., & MacEwan, D. J. (2012). Bortezomib induces heme oxygenase-1 expression in multiple myeloma. CELL CYCLE, 11(12), 2248-2252. doi:10.4161/cc.20343

DOI
10.4161/cc.20343
Journal article

Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention.

Barrera, L. N., Cassidy, A., Johnson, I. T., Bao, Y., & Belshaw, N. J. (2012). Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention.. The Proceedings of the Nutrition Society, 71(2), 237-245. doi:10.1017/s002966511200016x

DOI
10.1017/s002966511200016x
Journal article

2011

Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.

Drew, J. E., Mayer, C. -D., Farquharson, A. J., Young, P., & Barrera, L. N. (2011). Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.. The Journal of molecular diagnostics : JMD, 13(2), 233-242. doi:10.1016/j.jmoldx.2010.10.001

DOI
10.1016/j.jmoldx.2010.10.001
Journal article

2008

S1996 Role of Chronic Inflammation in Sporadic Colorectal Neoplasia

McLean, M. H., Drew, J. E., Mayer, C. D., Farquharson, A., Barrera, L. N., Fyfe, N., . . . El-Omar, E. (2008). S1996 Role of Chronic Inflammation in Sporadic Colorectal Neoplasia. Gastroenterology, 134(4). doi:10.1016/s0016-5085(08)61366-9

DOI
10.1016/s0016-5085(08)61366-9
Journal article

2007

Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine.

Drew, J. E., Farquharson, A. J., Padidar, S., Duthie, G. G., Mercer, J. G., Arthur, J. R., . . . Barrera, L. N. (2007). Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine.. American journal of physiology. Gastrointestinal and liver physiology, 293(4), G682-G691. doi:10.1152/ajpgi.00231.2007

DOI
10.1152/ajpgi.00231.2007
Journal article

2006

Complex regulation of mucosal pentraxin (Mptx) revealed by discrete micro-anatomical locations in colon.

Drew, J. E., Farquharson, A. J., Keijer, J., & Barrera, L. N. (2006). Complex regulation of mucosal pentraxin (Mptx) revealed by discrete micro-anatomical locations in colon.. Biochimica et biophysica acta, 1762(9), 844-848. doi:10.1016/j.bbadis.2006.07.011

DOI
10.1016/j.bbadis.2006.07.011
Journal article